Table 1 Microbiome study sample groups, descriptions, and respective sample sizes.
Treatment outcomes | Group | Group description | Sample size |
|---|---|---|---|
Successful therapy (ST) | Pre-ST | Baseline positive samples of successfully treated individuals | 16 |
Post-ST | Post-treatment samples of successfully treated individuals | 16 | |
Failed therapy (FT) | Pre-FT | Baseline positive samples of individuals that failed treatment | 11 |
Post-FT | Post-treatment samples of individuals that failed treatment | 11 | |
Successive reinfection | SR | Samples from individuals that were reinfected post successful treatment at multiple timepoints | 16 |
Constant therapy failure | CTF | Samples from individual that remained positive at all timepoints | 6 |
No treatment controls | NTC | Baseline negative samples | 21 |
